187 related articles for article (PubMed ID: 10936358)
21. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
22. Complement-regulatory proteins in ovarian malignancies.
Bjørge L; Hakulinen J; Wahlström T; Matre R; Meri S
Int J Cancer; 1997 Jan; 70(1):14-25. PubMed ID: 8985085
[TBL] [Abstract][Full Text] [Related]
23. A study of human DAF, CD59, MCP transgene in xenotransplantation.
Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
[No Abstract] [Full Text] [Related]
24. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease.
Davies ME; Horner A; Loveland BE; McKenzie IF
Scand J Rheumatol; 1994; 23(6):316-21. PubMed ID: 7528443
[TBL] [Abstract][Full Text] [Related]
25. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
[TBL] [Abstract][Full Text] [Related]
26. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury.
Song WC
Curr Dir Autoimmun; 2004; 7():181-99. PubMed ID: 14719381
[TBL] [Abstract][Full Text] [Related]
27. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of a pig line transgenic for human membrane cofactor protein.
Zhou CY; McInnes E; Parsons N; Langford G; Lancaster R; Richards A; Pino-Chavez G; Dos Santos Cruz G; Copeman L; Carrington C; Thompson S
Xenotransplantation; 2002 May; 9(3):183-90. PubMed ID: 11983016
[TBL] [Abstract][Full Text] [Related]
29. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.
Bardenstein DS; Dietz Y; Lass JH; Medof ME
Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649
[TBL] [Abstract][Full Text] [Related]
30. Analysis of membrane-bound complement regulatory proteins in prostate cancer.
Loberg RD; Wojno KJ; Day LL; Pienta KJ
Urology; 2005 Dec; 66(6):1321-6. PubMed ID: 16360477
[TBL] [Abstract][Full Text] [Related]
31. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
Gorter A; Meri S
Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
[TBL] [Abstract][Full Text] [Related]
32. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
33. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y
Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355
[TBL] [Abstract][Full Text] [Related]
34. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
[TBL] [Abstract][Full Text] [Related]
35. Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation?
Loveland BE; Cooper DK; Sandrin MS
Transplantation; 2000 Aug; 70(4):567-8. PubMed ID: 10972209
[No Abstract] [Full Text] [Related]
36. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
37. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
[No Abstract] [Full Text] [Related]
38. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
Seya T
Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
[No Abstract] [Full Text] [Related]
39. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
Brooimans RA; van Wieringen PA; van Es LA; Daha MR
Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
[TBL] [Abstract][Full Text] [Related]
40. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]